Ophthalmic Drugs Market Expands with Advancements in Drug Delivery Technologies

The global Ophthalmic Drugs Market was valued at approximately USD 35.4 billion in 2025 and is projected to reach nearly USD 67.9 billion by 2035, expanding at a CAGR of around 6.1% during the forecast period. The market's growth is driven by the increasing prevalence of eye disorders such as glaucoma, dry eye syndrome, cataracts, and age-related macular degeneration, along with the rising geriatric population and growing awareness regarding early diagnosis and treatment of vision-related diseases.

Request the Sample Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1769